Minen Mia T, Schaubhut Kathryn B, Morio Kaitlyn
NYU Langone Health, Department of Neurology, 222 E 41st, Ninth floor, New York, NY, 10017.
Columbia University, Post-baccalaureate Premed Program, 408 Lewisohn Hall, 2970 Broadway, New York, NY 10027.
Mult Scler Relat Disord. 2020 Nov;46:102489. doi: 10.1016/j.msard.2020.102489. Epub 2020 Sep 8.
Multiple Sclerosis (MS) and Migraine are comorbid neurologic conditions. Migraine prevalence is three times higher in the MS clinic population compared to the general population, and patients with MS and migraine are more symptomatic than patients with MS without migraine.
We sought to conduct a pilot feasibility and acceptability study of the RELAXaHEAD app in MS-Migraine patients and to assess whether there was any change in migraine disability and MS pain-related disability.
Randomized controlled study of patients with MS-migraine ages 18-80 years with 4+ headache days/ month who were willing to engage in smartphone based behavioral therapy. Half received the RELAXaHEAD app with progressive muscle relaxation (PMR) and the other half received the app without the PMR. Data was collected for 90 days on measures of recruitment, retention, engagement, and adherence to RELAXaHEAD. Preliminary data was also collected on migraine disability (MIDAS) and MS pain (PES).
Sixty-two subjects with MS-migraine were enrolled in the study (34 in PMR arm, 28 in monitored usual care arm). On average, during the 90 days, participants played the PMR on average 1.8 times per week, and for 12.9 min on days it was played. Forty-one percent (14/34) of the participants played the PMR two or more times weekly on average. Data was entered into the daily diaries, on average, 49% (44/90) of the days. There were major challenges in reaching subjects in follow-up for the efficacy data, and there was no significant change in migraine disability (MIDAS) scores or MS Pain (PES) scores from baseline to the endpoints. During the six-month follow-up, most patients felt either positively or neutral about the relaxation therapy.
There was interest in scalable accessible forms of behavioral therapy to treat migraine and MS-related pain in patients with MS and comorbid migraine. Similar to prior studies, a significant minority were willing to practice the PMR at least twice weekly. In the societal shift from telephone to more text and internet-based interactions, follow up was challenging, but those reached indicated that they appreciated the PMR and would recommend it to others. Future work should focus on engagement and efficacy.
多发性硬化症(MS)和偏头痛是共病的神经系统疾病。与普通人群相比,MS门诊人群中偏头痛的患病率高出三倍,且患有MS和偏头痛的患者比没有偏头痛的MS患者症状更明显。
我们试图对MS-偏头痛患者进行RELAXaHEAD应用程序的初步可行性和可接受性研究,并评估偏头痛残疾和MS疼痛相关残疾是否有任何变化。
对年龄在18-80岁、每月头痛天数≥4天且愿意参与基于智能手机的行为疗法的MS-偏头痛患者进行随机对照研究。一半患者接受带有渐进性肌肉松弛(PMR)的RELAXaHEAD应用程序,另一半患者接受没有PMR的该应用程序。收集90天内关于招募、留存、参与和对RELAXaHEAD应用程序依从性的测量数据。还收集了关于偏头痛残疾(MIDAS)和MS疼痛(PES)的初步数据。
62名患有MS-偏头痛的受试者参与了该研究(PMR组34名,监测常规治疗组28名)。在90天内,参与者平均每周播放PMR 1.8次,播放当天平均时长为12.9分钟。41%(14/34)的参与者平均每周播放PMR两次或更多次。数据平均有49%(44/90)的天数被录入每日日记。在获取疗效数据的随访中遇到了重大挑战,从基线到终点,偏头痛残疾(MIDAS)评分或MS疼痛(PES)评分没有显著变化。在六个月的随访中,大多数患者对放松疗法持积极或中立态度。
对于可扩展的、易于获得的行为疗法形式来治疗患有MS和共病偏头痛患者的偏头痛和MS相关疼痛存在兴趣。与先前的研究类似,少数人愿意每周至少进行两次PMR练习。在从电话到更多基于文本和互联网互动的社会转变中,随访具有挑战性,但接受随访的人表示他们欣赏PMR并会向他人推荐。未来的工作应侧重于参与度和疗效。